ARRIVENT BIOPHARMA, INC. (AVBP) ROE
- 2026-06-30: ROE -44.63%.
- 2026-03-31: ROE -44.83%.
- 2025-12-31: ROE -54.13%.
- 2025-09-30: ROE -49.64%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -44.63% |
| 2026-03-31 | -44.83% |
| 2025-12-31 | -54.13% |
| 2025-09-30 | -49.64% |
| 2025-06-30 | -54.82% |
| 2025-03-31 | -62.93% |
| 2024-12-31 | -31.24% |
| 2024-09-30 | -29.21% |
| 2024-06-30 | -25.24% |
| 2024-03-31 | -23.47% |
| 2023-12-31 | 45.26% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -54.13% |
| 2024-12-31 | -31.24% |
| 2023-12-31 | 45.26% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |